End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.9 TWD | +0.16% | +1.43% | +64.01% |
Apr. 19 | 3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | 3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 13.64M 422K | Sales 2023 | 20.63M 638K | Capitalization | 1.09B 33.67M |
---|---|---|---|---|---|
Net income 2022 | -67M -2.07M | Net income 2023 | -58M -1.79M | EV / Sales 2022 | 95.7 x |
Net cash position 2022 | 192M 5.93M | Net cash position 2023 | 156M 4.82M | EV / Sales 2023 | 45.2 x |
P/E ratio 2022 |
-22
x | P/E ratio 2023 |
-18.8
x | Employees | 33 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.74% |
1 day | +0.16% | ||
1 week | +1.43% | ||
1 month | -3.48% | ||
3 months | -9.12% | ||
6 months | +59.10% | ||
Current year | +64.01% |
Managers | Title | Age | Since |
---|---|---|---|
Keng Liang Ou
CEO | Chief Executive Officer | - | 15-01-14 |
Jui Wen Huang
DFI | Director of Finance/CFO | - | 17-04-17 |
Hsu An Pan
CTO | Chief Tech/Sci/R&D Officer | - | 20-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsien Chen
BRD | Director/Board Member | - | 20-11-18 |
Chi Ying Chiu
BRD | Director/Board Member | - | 20-11-18 |
Keng Liang Ou
CEO | Chief Executive Officer | - | 15-01-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 31.9 | +0.16% | 126,166 |
24-05-30 | 31.85 | +1.27% | 210,433 |
24-05-29 | 31.45 | -0.32% | 180,700 |
24-05-28 | 31.55 | -0.16% | 235,080 |
24-05-27 | 31.6 | +0.48% | 206,073 |
End-of-day quote Taipei Exchange, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+64.01% | 65.53M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.76% | 29.99B | |
+15.97% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- 6808 Stock